Lucira Health, Inc.
LHDX · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $42,629 | $74,267 | $149,343 | $336,047 |
| - Cash | $39,774 | $74,957 | $120,551 | $105,982 |
| + Debt | $48,091 | $48,225 | $31,184 | $2,829 |
| Enterprise Value | $50,946 | $47,535 | $59,976 | $232,894 |
| Revenue | $34,390 | $26,146 | $90,474 | $61,124 |
| % Growth | 31.5% | -71.1% | 48% | – |
| Gross Profit | -$99,555 | $7,992 | $39,916 | $12,625 |
| % Margin | -289.5% | 30.6% | 44.1% | 20.7% |
| EBITDA | -$124,159 | -$19,432 | $13,936 | -$6,557 |
| % Margin | -361% | -74.3% | 15.4% | -10.7% |
| Net Income | -$126,862 | -$21,677 | $13,078 | -$7,543 |
| % Margin | -368.9% | -82.9% | 14.5% | -12.3% |
| EPS Diluted | -3.15 | -0.54 | 0.31 | -0.19 |
| % Growth | -483.3% | -274.2% | 263.2% | – |
| Operating Cash Flow | -$28,243 | -$38,770 | -$5,302 | -$10,035 |
| Capital Expenditures | -$7,174 | -$6,093 | -$8,134 | -$4,614 |
| Free Cash Flow | -$35,417 | -$44,863 | -$13,436 | -$14,649 |